miR-21, miR-93, miR-191, miR-let-7b, and miR-499 Expression Level in Plasma and Cerebrospinal Fluid in Patients with Prolonged Disorders of Consciousness
In recent decades, significant progress has been achieved in understanding the mechanisms of disturbance and restoration of consciousness in patients after severe brain damage resulting in prolonged disorders of consciousness (pDOC). MicroRNAs (miRs) may be potential candidates as possible biomarker...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Neurology International |
Subjects: | |
Online Access: | https://www.mdpi.com/2035-8377/15/1/4 |
_version_ | 1797609706088300544 |
---|---|
author | Tatiana A. Petrova Sergey A. Kondratyev Anna A. Kostareva Roman V. Rutkovskiy Irina A. Savvina Ekaterina A. Kondratyeva |
author_facet | Tatiana A. Petrova Sergey A. Kondratyev Anna A. Kostareva Roman V. Rutkovskiy Irina A. Savvina Ekaterina A. Kondratyeva |
author_sort | Tatiana A. Petrova |
collection | DOAJ |
description | In recent decades, significant progress has been achieved in understanding the mechanisms of disturbance and restoration of consciousness in patients after severe brain damage resulting in prolonged disorders of consciousness (pDOC). MicroRNAs (miRs) may be potential candidates as possible biomarkers for the classification of disease subtypes, and prognosis in patients with pDOC. The aim of the study was to analyze miRs expression levels (hsa-miR-21-5p, hsa-miR-93-5p, hsa-miR-191-5p, mmu-miR-499-5p, hsa-let-7b-5p) by a real-time polymerase chain reaction in plasma and cerebrospinal fluid (CSF) from patients with pDOC and to identify a potential biomarker for dividing patients into groups according to disease severity. We analyzed the levels of investigated miRs in pDOC patients, divided by etiology, CRSI, and the total group compared with controls. Our results showed that dividing patients with pDOC into groups according to the etiology of the disease resulted in the most significant differences in the levels of miR-93, -21, and -191 in CSF and plasma samples between groups of patients. Among the analyzed miRs, we did not find a marker that would help to distinguish VS/UWS patient groups from MCS. Examining of miRs as possible prognostic markers in patients with pDOC, the starting point seems to be the cause that led to the development of the disease. |
first_indexed | 2024-03-11T06:04:49Z |
format | Article |
id | doaj.art-0dbb03e38c7e44f88d5606df69c9be3e |
institution | Directory Open Access Journal |
issn | 2035-8377 |
language | English |
last_indexed | 2024-03-11T06:04:49Z |
publishDate | 2022-12-01 |
publisher | MDPI AG |
record_format | Article |
series | Neurology International |
spelling | doaj.art-0dbb03e38c7e44f88d5606df69c9be3e2023-11-17T13:02:19ZengMDPI AGNeurology International2035-83772022-12-01151405410.3390/neurolint15010004miR-21, miR-93, miR-191, miR-let-7b, and miR-499 Expression Level in Plasma and Cerebrospinal Fluid in Patients with Prolonged Disorders of ConsciousnessTatiana A. Petrova0Sergey A. Kondratyev1Anna A. Kostareva2Roman V. Rutkovskiy3Irina A. Savvina4Ekaterina A. Kondratyeva5Almazov National Medical Research Centre, Institute of Molecular Biology and Genetics, 197341 St. Petersburg, RussiaAlmazov National Medical Research Centre, Polenov Neurosurgical Institute, 191014 St. Petersburg, RussiaAlmazov National Medical Research Centre, Institute of Molecular Biology and Genetics, 197341 St. Petersburg, RussiaAlmazov National Medical Research Centre, Anesthesiology and Intensive Care Department #12, 197341 St. Petersburg, RussiaAlmazov National Medical Research Centre, Polenov Neurosurgical Institute, 191014 St. Petersburg, RussiaAlmazov National Medical Research Centre, Polenov Neurosurgical Institute, 191014 St. Petersburg, RussiaIn recent decades, significant progress has been achieved in understanding the mechanisms of disturbance and restoration of consciousness in patients after severe brain damage resulting in prolonged disorders of consciousness (pDOC). MicroRNAs (miRs) may be potential candidates as possible biomarkers for the classification of disease subtypes, and prognosis in patients with pDOC. The aim of the study was to analyze miRs expression levels (hsa-miR-21-5p, hsa-miR-93-5p, hsa-miR-191-5p, mmu-miR-499-5p, hsa-let-7b-5p) by a real-time polymerase chain reaction in plasma and cerebrospinal fluid (CSF) from patients with pDOC and to identify a potential biomarker for dividing patients into groups according to disease severity. We analyzed the levels of investigated miRs in pDOC patients, divided by etiology, CRSI, and the total group compared with controls. Our results showed that dividing patients with pDOC into groups according to the etiology of the disease resulted in the most significant differences in the levels of miR-93, -21, and -191 in CSF and plasma samples between groups of patients. Among the analyzed miRs, we did not find a marker that would help to distinguish VS/UWS patient groups from MCS. Examining of miRs as possible prognostic markers in patients with pDOC, the starting point seems to be the cause that led to the development of the disease.https://www.mdpi.com/2035-8377/15/1/4miRprolonged disorders of consciousnessvegetative state/unresponsive wakefulness syndromeminimally consciousness statetraumatic brain injuryhypoxia |
spellingShingle | Tatiana A. Petrova Sergey A. Kondratyev Anna A. Kostareva Roman V. Rutkovskiy Irina A. Savvina Ekaterina A. Kondratyeva miR-21, miR-93, miR-191, miR-let-7b, and miR-499 Expression Level in Plasma and Cerebrospinal Fluid in Patients with Prolonged Disorders of Consciousness Neurology International miR prolonged disorders of consciousness vegetative state/unresponsive wakefulness syndrome minimally consciousness state traumatic brain injury hypoxia |
title | miR-21, miR-93, miR-191, miR-let-7b, and miR-499 Expression Level in Plasma and Cerebrospinal Fluid in Patients with Prolonged Disorders of Consciousness |
title_full | miR-21, miR-93, miR-191, miR-let-7b, and miR-499 Expression Level in Plasma and Cerebrospinal Fluid in Patients with Prolonged Disorders of Consciousness |
title_fullStr | miR-21, miR-93, miR-191, miR-let-7b, and miR-499 Expression Level in Plasma and Cerebrospinal Fluid in Patients with Prolonged Disorders of Consciousness |
title_full_unstemmed | miR-21, miR-93, miR-191, miR-let-7b, and miR-499 Expression Level in Plasma and Cerebrospinal Fluid in Patients with Prolonged Disorders of Consciousness |
title_short | miR-21, miR-93, miR-191, miR-let-7b, and miR-499 Expression Level in Plasma and Cerebrospinal Fluid in Patients with Prolonged Disorders of Consciousness |
title_sort | mir 21 mir 93 mir 191 mir let 7b and mir 499 expression level in plasma and cerebrospinal fluid in patients with prolonged disorders of consciousness |
topic | miR prolonged disorders of consciousness vegetative state/unresponsive wakefulness syndrome minimally consciousness state traumatic brain injury hypoxia |
url | https://www.mdpi.com/2035-8377/15/1/4 |
work_keys_str_mv | AT tatianaapetrova mir21mir93mir191mirlet7bandmir499expressionlevelinplasmaandcerebrospinalfluidinpatientswithprolongeddisordersofconsciousness AT sergeyakondratyev mir21mir93mir191mirlet7bandmir499expressionlevelinplasmaandcerebrospinalfluidinpatientswithprolongeddisordersofconsciousness AT annaakostareva mir21mir93mir191mirlet7bandmir499expressionlevelinplasmaandcerebrospinalfluidinpatientswithprolongeddisordersofconsciousness AT romanvrutkovskiy mir21mir93mir191mirlet7bandmir499expressionlevelinplasmaandcerebrospinalfluidinpatientswithprolongeddisordersofconsciousness AT irinaasavvina mir21mir93mir191mirlet7bandmir499expressionlevelinplasmaandcerebrospinalfluidinpatientswithprolongeddisordersofconsciousness AT ekaterinaakondratyeva mir21mir93mir191mirlet7bandmir499expressionlevelinplasmaandcerebrospinalfluidinpatientswithprolongeddisordersofconsciousness |